Tag Archives: Cell Culture Market

Cell Culture Market Trends And Opportunities For The Industry By 2022

The global cell culture market is currently dominated by three major companies who together hold 52% of the market share. Thermo Fisher Scientific ranks on top with 32.9% of the market share, followed by BD Biosciences and EMD Millipore respectively. BD Biosciences has a strong presence in developed economies such as EU5 nations and U.S. Sigma-Aldrich is also a key player in the cell culture consumables business such as media, reagents, and sera. Corning Life Sciences offers economical platforms as compared to other companies. The report finds that high product differentiation plays a major role in determining the market position of the players. A large number of small players are entering the market too, especially in emerging economies, and the outsourcing of cell culture processes to cell culture companies has also increased the competition.

The global cell culture market was valued at US$6.0 bn in 2013 and is projected to reach US$11.3 bn by 2022, expanding at a CAGR of 7.1% during the forecast period.

This 127 page report gives readers a comprehensive overview of the cell culture market. Browse through 12 data tables and 49 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/cell-culture-market.html

Geographically, North America accounted for US$2.2 bn in 2013 and is expected to continue as the primary market for cell culture. Asia Pacific is projected to experience the strongest overall growth rate. By product type, consumables had the most significant demand valuation at US$3.4 bn in 2013 and the pattern is anticipated to continue.

Massive Investments Driving Cell Culture Market

Numerous sectors such as research, bioprocessing and manufacturing, academics, and regenerative medicines use cell culture, which has led to a growing demand for these products. As a result, leading pharmaceutical companies are now focusing on increasing their capabilities into biopharmaceutical manufacturing by entering into alliances with biotech companies. For instance, Thermo Fisher Scientific acquired Life Technologies in February 2014 to establish a stronghold over the cell culture market.

Massive capital investments and specificity of each bio-manufacturing process is leading to a shift toward contract manufacturing and research. Furthermore, the expanding scope of cell culture in areas such as stem cell research is also proving to be a positive influence on the market.

Artificial organs are engineered biological substitutes used to replace the structure and restore the functions of an impaired or diseased organ. The market for artificial organs is projected to expand at a double-digit CAGR during the forecast period. Moreover, the trend toward serum-free, specialty and customized media solutions is expected to boost market growth and the applicability of cell culture technology.

Demand for Advanced Manufacturing Capabilities to Fulfill Requirements

The process of cell culture is complex and requires monitoring several parameters such as temperature, humidity, nutrients, and toxins. Any deviation from the precise handling technique could have an impact on the efficacy of the end product. These constraints are expected to bottleneck the process of cell culture development and manufacturing.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving cell culture market during 2014 – 2022: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

Moreover, the growth of the cell culture market is also likely to be affected by the development of alternative technologies such as transgenic animals and plants for biopharmaceutical production. Ethical concerns over the use of animal sources is another aspect that may curtail the cell culture market growth.

“Cell culture model systems in drug discovery and drug evaluation is opening up significant possibilities for market growth and 3D cell culture is acting as a future opportunity in in vitro analysis too,” reveals the author of the report.

The information presented in this review is based on a Transparency Market Research report, titled, “Cell Culture Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022.”

 

Advertisements

Cell Culture Market Trends And Opportunities For The Industry By 2022

The vendor landscape in the global cell culture market includes players such as VWR International LLC, Thermo Fisher Scientific Inc., GE Healthcare, Lonza Group Ltd., Becton, Dickinson & Co., Sigma-Aldrich Co. LLC., Corning Life Sciences B.V., EMD Millipore, PromoCell GmbH, and Wheaton Industries Inc. According to a TMR analyst, mergers and acquisitions among the key players are expected to strengthen the market in the coming years.

Cell Culture Consumables Register Higher Demand than Serums and Reagents

The market players are registering increased demand for cell culture across the medical research sector. Cell cultures are being increasingly applied across drug screening and monitoring, disease diagnosis, biologic manufacturing, IVF technology, cancer research, and stem cell research. Increased investments by private medical organizations and government organizations have supported the growth of the global cell culture market. TMR states that among the cell culture consumables, cell culture media register the highest demand compared to serums and reagents. This is due to the key importance of the nature of the culture medium to the health of the cells.

This 127 page report gives readers a comprehensive overview of the cell culture market. Browse through 12 data tables and 49 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/cell-culture-market.html

3D Cell Culture to Define Future of Global Cell Culture Market

The growing demand for biopharmaceuticals and artificial organs, coupled with the emerging trend towards serum-free, customized and specialty media solutions is the primary factor contributing towards the growth of the global cell culture market. The increasing focus on stem cell research would further expand the scope of the market in future. TMR recommends that the focus on backward integration to conduct in-house research and sustaining pricing pressures amid a weak global economic scenario will open up significant opportunities for the market players.

However, ethical concern over the usage of animal sources in cell culture is one of the major restraints in the growth of the market. The usage of transgenic plants and animals, and stringent process controls will also impede the growth of the market in the years to come. “3D cell culture has the potential to serve as the future growth opportunity for the market and in vitro analysis.” a TMR analyst predicts.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving cell culture market during 2014 – 2022: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

Asia Pacific to Register Highest Demand for Cell Culture

TMR predicts that among the key regions in the global cell culture market, Asia Pacific will register the fastest growth during the period between 2014 and 2022. “The improvement in economic conditions of the developing countries in the Asia Pacific region such as China and India is anticipated to support the market’s growth,” the analyst states. In 2013, North America was the leading region in the market.

TMR finds that the various opportunities in the global cell culture market will propel the expansion of the market at a CAGR of 7.1% during the period from 2014 to 2022. This would lead to an increase in the valuation of the market from US$6.1 bn in 2013 to US$11.3 bn in 2022.

The review is based on the conclusions of a TMR report titled “Cell Culture Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022.”

 

Cell Culture Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022

The global cell culture market is currently dominated by three major companies who together hold 52% of the market share. Thermo Fisher Scientific ranks on top with 32.9% of the market share, followed by BD Biosciences and EMD Millipore respectively. BD Biosciences has a strong presence in developed economies such as EU5 nations and U.S. Sigma-Aldrich is also a key player in the cell culture consumables business such as media, reagents, and sera. Corning Life Sciences offers economical platforms as compared to other companies. The report finds that high product differentiation plays a major role in determining the market position of the players. A large number of small players are entering the market too, especially in emerging economies, and the outsourcing of cell culture processes to cell culture companies has also increased the competition.

The global cell culture market was valued at US$6.0 bn in 2013 and is projected to reach US$11.3 bn by 2022, expanding at a CAGR of 7.1% during the forecast period.

Geographically, North America accounted for US$2.2 bn in 2013 and is expected to continue as the primary market for cell culture. Asia Pacific is projected to experience the strongest overall growth rate. By product type, consumables had the most significant demand valuation at US$3.4 bn in 2013 and the pattern is anticipated to continue.

Massive Investments Driving Cell Culture Market

Numerous sectors such as research, bioprocessing and manufacturing, academics, and regenerative medicines use cell culture, which has led to a growing demand for these products. As a result, leading pharmaceutical companies are now focusing on increasing their capabilities into biopharmaceutical manufacturing by entering into alliances with biotech companies. For instance, Thermo Fisher Scientific acquired Life Technologies in February 2014 to establish a stronghold over the cell culture market.

Massive capital investments and specificity of each bio-manufacturing process is leading to a shift toward contract manufacturing and research. Furthermore, the expanding scope of cell culture in areas such as stem cell research is also proving to be a positive influence on the market.

Artificial organs are engineered biological substitutes used to replace the structure and restore the functions of an impaired or diseased organ. The market for artificial organs is projected to expand at a double-digit CAGR during the forecast period. Moreover, the trend toward serum-free, specialty and customized media solutions is expected to boost market growth and the applicability of cell culture technology.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

Demand for Advanced Manufacturing Capabilities to Fulfill Requirements

The process of cell culture is complex and requires monitoring several parameters such as temperature, humidity, nutrients, and toxins. Any deviation from the precise handling technique could have an impact on the efficacy of the end product. These constraints are expected to bottleneck the process of cell culture development and manufacturing.

Moreover, the growth of the cell culture market is also likely to be affected by the development of alternative technologies such as transgenic animals and plants for biopharmaceutical production. Ethical concerns over the use of animal sources is another aspect that may curtail the cell culture market growth.

“Cell culture model systems in drug discovery and drug evaluation is opening up significant possibilities for market growth and 3D cell culture is acting as a future opportunity in in vitro analysis too,” reveals the author of the report.

The information presented in this review is based on a Transparency Market Research report, titled, “Cell Culture Market : Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022.”

 

Global Cell Culture Market to Reach US$11.3 bn by 2022 due to Rising Demand in Stem Cell, Cancer Research

The vendor landscape in the global cell culture market includes players such as VWR International LLC, Thermo Fisher Scientific Inc., GE Healthcare, Lonza Group Ltd., Becton, Dickinson & Co., Sigma-Aldrich Co. LLC., Corning Life Sciences B.V., EMD Millipore, PromoCell GmbH, and Wheaton Industries Inc. According to a TMR analyst, mergers and acquisitions among the key players are expected to strengthen the market in the coming years.

Cell Culture Consumables Register Higher Demand than Serums and Reagents

The market players are registering increased demand for cell culture across the medical research sector. Cell cultures are being increasingly applied across drug screening and monitoring, disease diagnosis, biologic manufacturing, IVF technology, cancer research, and stem cell research. Increased investments by private medical organizations and government organizations have supported the growth of the global cell culture market. TMR states that among the cell culture consumables, cell culture media register the highest demand compared to serums and reagents. This is due to the key importance of the nature of the culture medium to the health of the cells.

3D Cell Culture to Define Future of Global Cell Culture Market

The growing demand for biopharmaceuticals and artificial organs, coupled with the emerging trend towards serum-free, customized and specialty media solutions is the primary factor contributing towards the growth of the global cell culture market. The increasing focus on stem cell research would further expand the scope of the market in future. TMR recommends that the focus on backward integration to conduct in-house research and sustaining pricing pressures amid a weak global economic scenario will open up significant opportunities for the market players.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

However, ethical concern over the usage of animal sources in cell culture is one of the major restraints in the growth of the market. The usage of transgenic plants and animals, and stringent process controls will also impede the growth of the market in the years to come. “3D cell culture has the potential to serve as the future growth opportunity for the market and in vitro analysis.” a TMR analyst predicts.

Asia Pacific to Register Highest Demand for Cell Culture

TMR predicts that among the key regions in the global cell culture market, Asia Pacific will register the fastest growth during the period between 2014 and 2022. “The improvement in economic conditions of the developing countries in the Asia Pacific region such as China and India is anticipated to support the market’s growth,” the analyst states. In 2013, North America was the leading region in the market.

TMR finds that the various opportunities in the global cell culture market will propel the expansion of the market at a CAGR of 7.1% during the period from 2014 to 2022. This would lead to an increase in the valuation of the market from US$6.1 bn in 2013 to US$11.3 bn in 2022.

The review is based on the conclusions of a TMR report titled “Cell Culture Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022.”

Cell Culture Market Responds to Impressive Progress in Medicine and Healthcare

Cell-Culture-SystemsCell culture is the process by which eukaryotic or prokaryotic cells are grown outside their natural environment, under controlled laboratory conditions. It is one of the key tools used in molecular and cellular biology to study the physiology and biochemistry of cells (aging and metabolic studies), the effect of biomolecules and drugs on the cells, and carcinogenesis and mutagenesis studies. Cell culture has been identified as one of the fastest growing segments of the life sciences market.

The global cell culture market is undergoing significant transition in terms of product differentiation and new product launches in various market segments such as consumables and instruments. The cell culture market was valued at USD 6,097.0 million in 2013 and is projected to reach USD 11,314.5 million by 2022, expanding at a CAGR of 7.1% from 2014 to 2022. Increasing application areas of cell culture technology in cancer detection, drug discovery and manufacturing of biologics have triggered the growth of this market. In addition, utilization of cell culture in various applications such as developing model systems for research, studies of cellular structures and functions, stem cell research and genetic engineering. Furthermore, huge investment in research and development by life science companies, extensive academic and industry collaborations and innovation in stem cell research have also driven the global cell culture market. Use of cell and tissue culture as model systems for studying cellular mechanisms related to various diseases such as diabetes, Parkinson’s and Alzheimer’s, and evaluating drug response is one of the most promising applications of this technology.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=405

The cell culture market has been segmented into two major product types: consumables and instruments. Cell culture consumables have been further categorized into media, sera and reagents. Cell culture media is likely to be the fastest growing segment owing to increasing preference for animal-derived component free (ADCF) media due to ethical and quality concerns. The instruments segment includes culture systems, incubators, pipetting instruments, roller bottle equipment, biosafety cabinets, cryostorage equipment, and others. Technological innovations in the design and operation of cell culture instruments and rapid adoption of automated culture systems by researchers and manufacturers are the major factors driving the segment.

Based on geography, the cell culture market is segmented into North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America was recognized as the largest regional market globally in 2013. Ongoing robust research activities for the development of drugs and biologics and presence of major pharmaceutical, biotechnology and food and beverages companies in the region are some of the driving factors in this region. Europe held the second position in terms of revenue in 2013. Asia Pacific is expected to be the fastest growing cell culture market during the forecast period from 2014 to 2022, due to improving economic condition in countries such as India and China, and increasing number of contract manufacturing and contract research organizations in Asia Pacific. Japan, China, Australia, and India are the major markets in Asia Pacific that offer immense opportunities to the companies in the cell culture market. Continuous increase in health care expenditure in China and India are expected to play a key role in driving growth in these markets. The markets in Rest of the World (RoW) and Latin America would also grow significantly due to increasing public and private investment in life science researches, in particular cell culture. In addition, factors such as improving health care infrastructure, rising awareness, and flexible regulatory requirements in the region are driving the growth of the cell culture market.

Key players operating in the global cell culture market include Sigma-Aldrich Corporation, BD Biosciences, EMD Millipore, Thermo Fisher Scientific, Inc., GE Healthcare, Lonza Biosciences, VWR International, PromoCell GmbH and Corning Incorporated.